YoVDO

Innovations in First Line Therapy for DLBCL - 7 February 2024

Offered By: Stanford Department of Medicine via YouTube

Tags

Oncology Courses Hematology Courses Clinical Trials Courses Cancer Treatment Courses Cancer Research Courses Targeted Therapy Courses Immunotherapy Courses Lymphomas Courses

Course Description

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Explore cutting-edge advancements in first-line therapy for Diffuse Large B-Cell Lymphoma (DLBCL) in this informative Grand Rounds presentation. Led by Dr. Christopher Flowers, Head of the Division of Cancer Medicine and Chair of the Department of Lymphoma/Myeloma at The University of Texas MD Anderson Cancer Center, the 54-minute talk delves into the latest research and treatment strategies. Gain valuable insights into innovative approaches that are shaping the future of DLBCL management and improving patient outcomes. This presentation, hosted by the Stanford Department of Medicine, offers a unique opportunity to stay abreast of the evolving landscape in lymphoma treatment.

Syllabus

Innovations in First Line Therapy for DLBCL | DoM Grand Rounds | 7 February 2024


Taught by

Stanford Department of Medicine

Related Courses

Introduction to Applied Biostatistics: Statistics for Medical Research
Osaka University via edX Introduction to Breast Cancer
Yale University via Coursera Introduction to the Biology of Cancer
Johns Hopkins University via Coursera Clinical Trials: Good Clinical Practice
Novartis via Coursera Data Sciences in Pharma - Patient Centered Outcomes Research
Genentech via Coursera